William Sievert

14.2k citations

154 papers · 6.5k indexed · 2 hit papers · h-index 35

Impact in

Hepatology top 0.1%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Hepatitis Viruses Studies and Epidemiology
- Liver physiology and pathology
Epidemiology top 0.2%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment

Papers in ⓘ

Hepatology 114
- Hepatitis C virus research 85
- Liver Disease and Transplantation 18
- Liver physiology and pathology 14
- Hepatitis Viruses Studies and Epidemiology 9
Epidemiology 110
- Liver Disease Diagnosis and Treatment 79
- Hepatitis B Virus Studies 69

Co-authors: Patrick Marcellin (12 shared papers)Seng Gee Lim (10 shared papers)Myron J. Tong (7 shared papers)Edward Gane (6 shared papers)Marı́a Buti (7 shared papers)John F. Flaherty (2 shared papers)Carol Brosgart (7 shared papers)John Fry (7 shared papers)
Journals: Journal of Hepatology (25 papers)Hepatology (13 papers)Journal of Gastroenterology and Hepatology (12 papers)The Medical Journal of Australia (7 papers)Gastroenterology (7 papers)
Partner nations: Australia United States United Kingdom

In The Last Decade

William Sievert

145 papers receiving 6.3k citations

Hit Papers

align trajectories log scale

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study 2012 · 1.3k citations

Peers

Countries citing papers authored by William Sievert

Since Specialization

Citations

This map shows the geographic impact of William Sievert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Sievert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Sievert more than expected).

Fields of papers citing papers by William Sievert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Sievert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Sievert. The network helps show where William Sievert may publish in the future.

Co-authors

The 25 scholars most cited alongside William Sievert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with William Sievert Line = papers co-authored together William Sievert links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 154 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study The Lancet ·Patrick Marcellin, Edward Gane, Marı́a Buti, Nezam H. Afdhal, William Sievert, Ira M. Jacobson, M. Kay Washington, G. Germanidis, John F. Flaherty, Raul Aguilar Schall, Jeffrey D. Bornstein, Kathryn M. Kitrinos, G. Mani Subramanian, John G. McHutchison, E. Jenny Heathcote Hit paper breakdown →	2012	1274
2	Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis B New England Journal of Medicine ·Patrick Marcellin, Ting‐Tsung Chang, Seng Gee Lim, Myron J. Tong, William Sievert, Mitchell L. Shiffman, Lennox J. Jeffers, Zachary Goodman, Michael Wulfsohn, Shelly Xiong, John Fry, Carol Brosgart Hit paper breakdown →	2003	1010
3	Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to Lamivudine Antimicrobial Agents and Chemotherapy ·Daniel J. Tenney, Steven M. LeVine, R.E. Rose, Ann W. Walsh, Steven P. Weinheimer, Linda Discotto, Mary Jane Plym, Kevin A. Pokornowski, Cheng-Fang Yu, P. Angus, A. Ayres, Angeline Bartholomeusz, William Sievert, Geoff Thompson, Nadia Warner, Stephen Locarnini, Richard J. Colonno	2004	411
4	Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis B Hepatology ·Patrick Marcellin, Ting‐Tsung Chang, Seng Gee Lim, William Sievert, Myron J. Tong, Sarah Arterburn, Katyna Borroto–Esoda, David Frederick, Franck Rousseau	2008	235
5	STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation Cancer Cell ·Hazel Tye, Catherine L. Kennedy, Meri Najdovska, Louise McLeod, William McCormack, Norman R. Hughes, Anouk Dev, William Sievert, Chia-Huey Ooi, Tomo‐o Ishikawa, Hiroko Oshima, Prithi S. Bhathal, Andrew E. Parker, Masanobu Oshima, Patrick Tan, Brendan J. Jenkins	2012	228
6	Amnion Epithelial Cell-Derived Exosomes Restrict Lung Injury and Enhance Endogenous Lung Repair Stem Cells Translational Medicine ·Jean L. Tan, Sin N. Lau, Bryan Leaw, Hong Phuong Nguyen, Lois A. Salamonsen, Mohamed I. Saad, Siow Teng Chan, Dandan Zhu, Mirja Krause, Carla F. Kim, William Sievert, Euan M. Wallace, Rebecca Lim	2018	161
7	Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B Gut ·Scott J. Patterson, Jacob George, Simone I. Strasser, A. U. Lee, William Sievert, Amanda Nicoll, P. V. Desmond, Stuart K. Roberts, S. Locarnini, S. Bowden, Peter Angus	2010	153
8	Transplantation of Human Amnion Epithelial Cells Reduces Hepatic Fibrosis in Immunocompetent CCl₄-Treated Mice Cell Transplantation ·Ursula Manuelpillai, Jorge Tchongue, Dinushka Lourensz, Vijesh Vaghjiani, Chrishan S. Samuel, Alison Liu, Elizabeth D. Williams, William Sievert	2010	121
9	Efficacy of Entecavir With or Without Tenofovir Disoproxil Fumarate for Nucleos(t)ide-Naïve Patients With Chronic Hepatitis B Gastroenterology ·Anna S. Lok, Huy Trinh, Giampiero Carosi, Ulus Salih Akarca, Adrián Gadano, François Habersetzer, William Sievert, David Wong, Meghan Lovegren, David J. Cohen, Cyril Llamoso	2012	111
10	Early detection of protein depletion in alcoholic cirrhosis: Role of body composition analysis Gastroenterology ·Dwi Prijatmoko, Boyd J. Strauss, John Lambert, William Sievert, Dan B. Stroud, Mark L. Wahlqvist, Benjamin Katz, John Colman, Penelope Jones, M. G. Korman	1993	103
11	Ten‐year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B virus infection Liver International ·Patrick Marcellin, David Wong, William Sievert, Peter Buggisch, Jörg Petersen, Robert Flisiak, Michael P. Manns, Kelly Kaita, Zahari Krastev, Samuel S. Lee, Andrea L. Cathcart, Gerald Crans, Marjoleine Op den Brouw, Belinda Jump, Anuj Gaggar, John F. Flaherty, Marı́a Buti	2019	101
12	Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis American Journal of Physiology-Gastrointestinal and Liver Physiology ·Shane Patella, David J. Phillips, Jorge Tchongue, David M. de Kretser, William Sievert	2005	96
13	Human Amniotic Epithelial Cell Transplantation Induces Markers of Alternative Macrophage Activation and Reduces Established Hepatic Fibrosis PLoS ONE ·Ursula Manuelpillai, Dinushka Lourensz, Vijesh Vaghjiani, Jorge Tchongue, Derek Lacey, Jing Yang Tee, Padma Murthi, James Chan, Alexander Hodge, William Sievert	2012	90
14	Southeast Asian patients with chronic hepatitis C: The impact of novel genotypes and race on treatment outcome Hepatology ·Anouk Dev, Rhonda McCaw, Vijaya Sundararajan, Scott Bowden, William Sievert	2002	87
15	Angiotensin-(1–7), an alternative metabolite of the renin–angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat Clinical Science ·John Lubel, Chandana B. Herath, Jorge Tchongue, Josephine Grace, Zhiyuan Jia, Karen R. Spencer, David Casley, Peter Crowley, William Sievert, Louise M. Burrell, Peter Angus	2009	86
16	Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial The Lancet. Gastroenterology & hepatology ·Man‐Fung Yuen, Kosh Agarwal, Edward Gane, Christian Schwabe, Sang Hoon Ahn, Dong Joon Kim, Young‐Suk Lim, Wendy Cheng, William Sievert, Kumar Visvanathan, Eric Ruby, Sandy Liaw, Ran Yan, Qi Huang, Richard J. Colonno, Uri Lopatin	2019	81
17	Fas‐mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection Journal of Viral Hepatitis ·Stephen Pianko, Shane Patella, George Ostapowicz, Paul Desmond, William Sievert	2001	77
18	Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells Hepatology ·Virginia Knight, Jorge Tchongue, Dinushka Lourensz, Peter G. Tipping, William Sievert	2011	73
19	A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan Hepatology International ·Heather Bennett, Nathalie Waser, Karissa Johnston, Jia‐Horng Kao, Young‐Suk Lim, Zhongping Duan, Youn Jae Lee, Lai Wei, Chien‐Jen Chen, William Sievert, Yong Yuan, Hong Li	2015	71
20	The Human Amnion Epithelial Cell Secretome Decreases Hepatic Fibrosis in Mice with Chronic Liver Fibrosis Frontiers in Pharmacology ·Majid Alhomrani, Jeanne Correia, Marcus J. Zavou, Bryan Leaw, Nathan Kuk, Rong Xu, Mohamed I. Saad, Alexander Hodge, David W. Greening, Rebecca Lim, William Sievert	2017	66

About William Sievert

William Sievert is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Gastroenterology and Surgery, having authored 154 papers that have together received 6.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (85 papers), Liver Disease Diagnosis and Treatment (79 papers), Hepatitis B Virus Studies (69 papers), Liver Disease and Transplantation (18 papers), Liver physiology and pathology (14 papers), Organ Transplantation Techniques and Outcomes (10 papers), Helicobacter pylori-related gastroenterology studies (9 papers) and Hepatitis Viruses Studies and Epidemiology (9 papers). The work is most often cited by research in Hepatology (4.6k citations), Epidemiology (4.8k citations), Infectious Diseases (680 citations), Genetics (279 citations) and Immunology (490 citations). William Sievert has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Patrick Marcellin, Seng Gee Lim, Myron J. Tong, Edward Gane, Marı́a Buti, John F. Flaherty, Carol Brosgart, John Fry, Ira M. Jacobson and Lennox J. Jeffers. Their work appears in journals such as Journal of Hepatology, Hepatology, Journal of Gastroenterology and Hepatology, The Medical Journal of Australia and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact